Monitor the December 2026 shareholder votes and receipt of regulatory approvals, particularly German foreign direct investment clearance. The outcome of Curaleaf's hostile bid and any competing proposals will also influence the deal's completion. Post-closing, focus on integration execution and realization of the C$50 million synergy target.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 3 $5.16entry
- T+1 · 13h ago +1.55%α −0.10% · $5.24
- T+5 · in 5d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Organigram Global Inc. (OGI) will acquire Aurora Cannabis Inc. (ACB) for C$7.80 per share in a cash-and-stock deal valued at approximately C$561 million. The offer represents a 93% premium to Aurora's unaffected price and a 21% premium to Curaleaf's hostile bid, which Aurora's board has rejected. The transaction is expected to close in January 2027, subject to shareholder and regulatory approvals.
Key Facts
- Organigram to acquire Aurora for C$7.80 per share, valuing Aurora at approximately C$561 million on a fully diluted equity value basis.
- Consideration represents a 93% premium to Aurora's unaffected share price as of August 10, 2026, and a 21% premium to Curaleaf's hostile bid as of November 2, 2026.
- Aurora shareholders can elect cash, Organigram shares, or a combination, subject to proration; aggregate consideration capped at C$253.6 million cash and 205.8 million Organigram shares.
- BAT (British American Tobacco) will invest C$187.5 million via a private placement at C$1.33 per share to help finance the cash portion.
- ATB Financial has committed up to $210 million in senior secured credit facilities to support the acquisition.
- Identified synergies exceed C$50 million from cross-selling, procurement scale, and consolidated distribution.
- Transaction has unanimous support from both boards; BAT and directors/officers have entered into voting support agreements.
- Aurora shareholders expected to hold approximately 35% pro forma economic ownership and 42% voting ownership of the combined company.
- Closing expected in January 2027, subject to shareholder votes in December 2026 and regulatory approvals.
Financial Impact
C$561 million enterprise value; C$7.80 per share consideration; 93% premium to unaffected price; C$187.5 million BAT private placement; C$210 million ATB credit facilities; C$50 million+ identified synergies.
Risk Factors
- Transaction may not receive required shareholder approvals (two-thirds of Aurora votes, simple majority excluding certain holders).
- Regulatory approvals, including German FDI clearance and TSX approval, may be delayed or denied.
- Curaleaf could improve its hostile bid or a competing bidder could emerge, potentially derailing the deal.
- Integration risks and failure to achieve the projected C$50 million in synergies.
- Financing conditions precedent include receipt of committed equity and final court order; any shortfall could delay or prevent closing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-121740 |
| Document: tm2628773d2_6k.htm | 0001104659-26-121740 |
| Document: 0001104659-26-121740-index-headers.html | 0001104659-26-121740 |
| Document: 0001104659-26-121740-index.html | 0001104659-26-121740 |
| Document: 0001104659-26-121740.txt | 0001104659-26-121740 |
| Earnings Context (Synthetic; results releases only) | 0001104659-26-121740 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 today | 6-K | $5.15 | awaiting T+5 | awaiting T+5 | $5.24 (+1.75%) |
Nov 3, 2026 1d ago | 6-K | $5.16 | awaiting T+5 | awaiting T+5 | $5.24 (+1.55%) |
Oct 29, 2026 6d ago | 6-K | $4.08 | awaiting T+5 | awaiting T+5 | $5.24 (+28.43%) |
Oct 26, 2026 9d ago | 6-K | $3.90 $4.06 | ▲ +4.10% | ▲ +5.36% | $5.24 (+34.36%) |
Oct 14, 2026 21d ago | 6-K | $4.10 $3.97 | ▼ −3.17% | ▼ −2.16% | $5.24 (+27.80%) |
Oct 8, 2026 27d ago | 6-K | $4.43 $4.10 | ▼ −7.45% | ▼ −7.17% | $5.24 (+18.28%) |
Oct 6, 2026 29d ago | 6-K | $4.46 $4.17 | ▼ −6.50% | ▼ −5.52% | $5.24 (+17.49%) |
Oct 5, 2026 4w ago | 6-K | $4.59 $4.29 | ▼ −6.54% | ▼ −6.40% | $5.24 (+14.16%) |
Sep 16, 2026 7w ago | 6-K | $3.83 $4.22 | ▲ +10.18% | ▲ +7.62% | $5.24 (+36.81%) |
Sep 14, 2026 7w ago | 6-K | $3.81 $4.03 | ▲ +5.77% | ▲ +5.67% | $5.24 (+37.53%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers